An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesotheliomaPASELLO, G; CERESOLI, G. L; FAVARETTO, A et al.Cancer treatment reviews. 2013, Vol 39, Num 1, pp 10-17, issn 0305-7372, 8 p.Article

Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinomaCERESOLI, G. L; DELL'ORO, S; PASSONI, P et al.Cancer. 2000, Vol 89, Num 1, pp 89-96, issn 0008-543XArticle

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyCERESOLI, G. L; GROSSO, F; PICCOLINI, E et al.British journal of cancer. 2014, Vol 111, Num 2, pp 220-226, issn 0007-0920, 7 p.Article

Therapeutic management with adriamycin-containing chemotherapy and radiotherapy of monostotic and polyostotic primary non-hodgkin's lymphoma of bone in adultsFERRERI, A. J. M; RENI, M; CERESOLI, G. L et al.Cancer investigation. 1998, Vol 16, Num 8, pp 554-561, issn 0735-7907Article

New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesotheliomaZUCALI, P. A; GIOVANNETTI, E; ASSARAF, Y. G et al.Annals of oncology. 2010, Vol 21, Num 7, pp 1560-1561, issn 0923-7534, 2 p.Article

Diagnostic and therapeutic management of neuroendocrine lung tumors : A clinical study of 44 casesCARRETTA, A; CERESOLI, G. L; ARRIGONI, G et al.Lung cancer. 2000, Vol 29, Num 3, pp 217-225, issn 0169-5002Article

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)CAPPUZZO, F; BARTOLINI, S; CRINO, L et al.British journal of cancer. 2004, Vol 90, Num 1, pp 82-86, issn 0007-0920, 5 p.Article

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trialCERESOLI, G. L; CAPPUZZO, F; GREGORC, V et al.Annals of oncology. 2004, Vol 15, Num 7, pp 1042-1047, issn 0923-7534, 6 p.Article

Role of dose intensity in conservative treatment of anal canal carcinoma : Report of 35 casesCERESOLI, G. L; FERRERI, A. J. M; CORDIO, S et al.Oncology. 1998, Vol 55, Num 6, pp 525-532, issn 0030-2414Article

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsZUCALI, P. A; RUIZ, M. G; RONCALLI, M et al.Annals of oncology. 2008, Vol 19, Num 9, pp 1605-1612, issn 0923-7534, 8 p.Article

EGFR overexpression in malignant pleural mesothelioma an immunohistochemical and molecular study with clinico-pathological correlationsDESTRO, A; CERESOLI, G. L; RIZZI, A et al.Lung cancer. 2006, Vol 51, Num 2, pp 207-215, issn 0169-5002, 9 p.Article

Malignant pleural mesotheliomaCERESOLI, G. L; BETTA, G. P; CASTAGNETO, B et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, ii13-ii16, SUP2Conference Paper

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaZUCALI, P. A; PERRINO, M; LORENZI, E et al.Lung cancer. 2014, Vol 84, Num 3, pp 265-270, issn 0169-5002, 6 p.Article

Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter surveyZUCALI, P. A; SIMONELLI, M; LORENZI, E et al.Lung cancer. 2012, Vol 75, Num 3, pp 360-367, issn 0169-5002, 8 p.Article

Differential diagnosis and management of focal ground-glass opacitiesINFANTE, M; LUTMAN, R. F; INZIRILLO, F et al.The European respiratory journal. 2009, Vol 33, Num 4, pp 821-827, issn 0903-1936, 7 p.Article

Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibCAPPUZZO, F; TOSCHI, L; TRISOLINI, R et al.Annals of oncology. 2006, Vol 17, Num 7, pp 1120-1127, issn 0923-7534, 8 p.Article

18-FDG positron emission tomography in the evaluation of malignant pleural diseases : a pilot studyCARRETTA, A; LANDONI, C; MELLONI, G et al.European journal of cardio-thoracic surgery. 2000, Vol 17, Num 4, pp 377-383, issn 1010-7940Conference Paper

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaCERESOLI, G. L; ZUCALI, P. A; SOTO-PARRA, H et al.British journal of cancer. 2013, Vol 109, Num 3, pp 552-558, issn 0007-0920, 7 p.Article

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma : combined analysis of two phase II trialsCERESOLI, G. L; CASTAGNETO, B; SALAMINA, S et al.British journal of cancer. 2008, Vol 99, Num 1, pp 51-56, issn 0007-0920, 6 p.Article

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsCAPPUZZO, F; TOSCHI, L; FRANKLIN, W. A et al.British journal of cancer. 2005, Vol 93, Num 12, pp 1334-1340, issn 0007-0920, 7 p.Article

Paclitaxel and carboplatin in combination with gemcitabine : A phase I-II trial in patients with advanced non-small-cell lung cancerFAVARETTO, A; CERESOLI, G. L; PACCAGNELLA, A et al.Annals of oncology. 2000, Vol 11, Num 11, pp 1421-1426, issn 0923-7534Article

A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiformeRENI, M; COZZARINI, C; FERRERI, A. J. M et al.Cancer investigation. 2000, Vol 18, Num 6, pp 510-515, issn 0735-7907Article

Primary cardiac lymphoma in immunocompetent patients: Diagnostic and therapeutic managementCERESOLI, G. L; FERRERI, A. J. M; BUCCI, E et al.Cancer. 1997, Vol 80, Num 8, pp 1497-1506, issn 0008-543XArticle